Literature DB >> 19272362

Mouse models for human otitis media.

Dennis R Trune1, Qing Yin Zheng.   

Abstract

Otitis media (OM) remains the most common childhood disease and its annual costs exceed $5 billion. Its potential for permanent hearing impairment also emphasizes the need to better understand and manage this disease. The pathogenesis of OM is multifactorial and includes infectious pathogens, anatomy, immunologic status, genetic predisposition, and environment. Recent progress in mouse model development is helping to elucidate the respective roles of these factors and to significantly contribute toward efforts of OM prevention and control. Genetic predisposition is recognized as an important factor in OM and increasing numbers of mouse models are helping to uncover the potential genetic bases for human OM. Furthermore, the completion of the mouse genome sequence has offered a powerful set of tools for investigating gene function and is generating a rich resource of mouse mutants for studying the genetic factors underlying OM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272362      PMCID: PMC2832702          DOI: 10.1016/j.brainres.2009.02.047

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  194 in total

1.  Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions.

Authors:  S S Ball; J Prazma; C G Dais; R J Triana; H C Pillsbury
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-08       Impact factor: 1.547

2.  Interleukin-8 and chemotactic activity of middle ear effusions.

Authors:  M Storgaard; K Larsen; S Blegvad; H Nødgaard; T Ovesen; P L Andersen; N Obel
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor.

Authors:  K Maxwell; G Leonard; D L Kreutzer
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-09

4.  Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins.

Authors:  X X Gu; C M Tsai; T Ueyama; S J Barenkamp; J B Robbins; D J Lim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Interleukin-8 concentration predicts the neutrophil count in middle ear effusion.

Authors:  P S Nassif; S Q Simpson; A A Izzo; P J Nicklaus
Journal:  Laryngoscope       Date:  1997-09       Impact factor: 3.325

6.  Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

Authors:  X X Gu; J Chen; S J Barenkamp; J B Robbins; C M Tsai; D J Lim; J Battey
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Murine model of interleukin-8-induced otitis media.

Authors:  M Johnson; G Leonard; D L Kreutzer
Journal:  Laryngoscope       Date:  1997-10       Impact factor: 3.325

8.  Blinded multiplex PCR analyses of middle ear and nasopharyngeal fluids from chinchilla models of single- and mixed-pathogen-induced otitis media.

Authors:  L O Bakaletz; G J White; J C Post; G D Ehrlich
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

9.  A mouse model for acute otitis media.

Authors:  Asa Melhus; Allen F Ryan
Journal:  APMIS       Date:  2003-10       Impact factor: 3.205

10.  Otitis media incidence and impact on the auditory brain stem response in lipopolysaccharide-nonresponsive C3H/HeJ mice.

Authors:  C R Mitchell; J B Kempton; B Scott-Tyler; D R Trune
Journal:  Otolaryngol Head Neck Surg       Date:  1997-11       Impact factor: 5.591

View more
  16 in total

Review 1.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

2.  Pathological features in the LmnaDhe/+ mutant mouse provide a novel model of human otitis media and laminopathies.

Authors:  Yan Zhang; Heping Yu; Min Xu; Fengchan Han; Cong Tian; Suejin Kim; Elisha Fredman; Jin Zhang; Cindy Benedict-Alderfer; Qing Yin Zheng
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

3.  Otitis media induced by peptidoglycan-polysaccharide (PGPS) in TLR2-deficient (Tlr2(-/-)) mice for developing drug therapy.

Authors:  Xiaolin Zhang; Tihua Zheng; Lu Sang; Luke Apisa; Hongchun Zhao; Fenghua Fu; Qingzhu Wang; Yanfei Wang; Qingyin Zheng
Journal:  Infect Genet Evol       Date:  2015-08-18       Impact factor: 3.342

4.  Mucin gene expression and mouse middle ear epithelium.

Authors:  Joseph E Kerschner; Jizhen Li; Katsuyuki Tsushiya; P Khampang
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-08       Impact factor: 1.675

5.  Scleraxis is required for differentiation of the stapedius and tensor tympani tendons of the middle ear.

Authors:  Lingyan Wang; Chris S Bresee; Han Jiang; Wenxuan He; Tianying Ren; Ronen Schweitzer; John V Brigande
Journal:  J Assoc Res Otolaryngol       Date:  2011-03-12

Review 6.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 7.  Biofilm models of polymicrobial infection.

Authors:  Rebecca A Gabrilska; Kendra P Rumbaugh
Journal:  Future Microbiol       Date:  2015-11-23       Impact factor: 3.165

Review 8.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

9.  Inner ear tissue remodeling and ion homeostasis gene alteration in murine chronic otitis media.

Authors:  Carol J MacArthur; Fran Hausman; J Beth Kempton; Nathan Sautter; Dennis R Trune
Journal:  Otol Neurotol       Date:  2013-02       Impact factor: 2.311

10.  Sh3pxd2b mice are a model for craniofacial dysmorphology and otitis media.

Authors:  Bin Yang; Cong Tian; Zhi-guang Zhang; Feng-chan Han; Rami Azem; Heping Yu; Ye Zheng; Ge Jin; James E Arnold; Qing Y Zheng
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.